Drugs Made In America Acquisition Corp. Ordinary Shares
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $261.0M
- Price
- $10.75
- % Change (Daily % change from the live per-ticker quote feed.)
- +0.23%
- Volume
- 82.2K
About
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
Quick stats
Shares outstanding24.3M
Computed float21.0M
Float / shares86.7%
Key info
SectorFinancial Services
IndustryShell Companies
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0002028614
Websitehttps://dmaacorp.com
AI Summary
AI-generated1/2
minorneutrallegal litigation
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—LXP, DMAA, PSNL, and FNWD
Monteverde & Associates PC announced it is investigating Drugs Made In America Acquisition Corp. regarding its proposed merger with Power Analytics Global Corp.
The firm is soliciting shareholders to contact them regarding potential claims, offering representation on a contingency basis with no cost or obligation.
This release is an attorney advertisement for lead plaintiff services and does not contain new operational or financial disclosures from the company.